Does ticagrelor improve CMR-based myocardial injury and long-term outcomes compared to clopidogrel in STEMI patients undergoing primary PCI?
ST-Elevation Myocardial Infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI)
Ticagrelor
Clopidogrel
CMR-based myocardial injury and long-term outcomessurrogate
In a pilot study of STEMI patients undergoing primary PCI, ticagrelor and clopidogrel demonstrated similar effects on CMR-based myocardial injury, providing feasibility data for future multicenter trials.
Ticagrelor and clopidogrel showed similar effects on CMR-based myocardial injury and long-term outcomes in STEMI patients undergoing PCI. These pilot findings are hypothesis-generating and support the feasibility and inform sample-size planning for future multicenter trials.
Building similarity graph...
Analyzing shared references across papers
Loading...
Wei‐Ting Wang
Guangzhou University of Chinese Medicine
Chiu-Yang Lee
Taipei Veterans General Hospital
Shao-Sung Huang
Taipei Veterans General Hospital
National Yang Ming Chiao Tung University
Taipei Veterans General Hospital
Institute of Clinical Research
Building similarity graph...
Analyzing shared references across papers
Loading...
Wang et al. (Thu,) studied this question.
synapsesocial.com/papers/69a75cb5c6e9836116a25d09 — DOI: https://doi.org/10.6515/acs.202601_42(1).20251008a